BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 11509741)

  • 1. Effect of phosphate transporter and methylation inhibitor drugs on the disposition of arsenate and arsenite in rats.
    Csanaky I; Gregus Z
    Toxicol Sci; 2001 Sep; 63(1):29-36. PubMed ID: 11509741
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of selenite on the disposition of arsenate and arsenite in rats.
    Csanaky I; Gregus Z
    Toxicology; 2003 Apr; 186(1-2):33-50. PubMed ID: 12604169
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Biliary and urinary excretion of inorganic arsenic: monomethylarsonous acid as a major biliary metabolite in rats.
    Gregus Z; Gyurasics A; Csanaky I
    Toxicol Sci; 2000 Jul; 56(1):18-25. PubMed ID: 10869450
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Species variations in the biliary and urinary excretion of arsenate, arsenite and their metabolites.
    Csanaky I; Gregus Z
    Comp Biochem Physiol C Toxicol Pharmacol; 2002 Mar; 131(3):355-65. PubMed ID: 11912060
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Role of glutathione in reduction of arsenate and of gamma-glutamyltranspeptidase in disposition of arsenite in rats.
    Csanaky I; Gregus Z
    Toxicology; 2005 Feb; 207(1):91-104. PubMed ID: 15590125
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dose-dependent biotransformation of arsenite in rats--not S-adenosylmethionine depletion impairs arsenic methylation at high dose.
    Csanaky I; Németi B; Gregus Z
    Toxicology; 2003 Feb; 183(1-3):77-91. PubMed ID: 12504344
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of an inactivator of glyceraldehyde-3-phosphate dehydrogenase, a fortuitous arsenate reductase, on disposition of arsenate in rats.
    Németi B; Csanaky I; Gregus Z
    Toxicol Sci; 2006 Mar; 90(1):49-60. PubMed ID: 16322075
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mitochondria work as reactors in reducing arsenate to arsenite.
    Németi B; Gregus Z
    Toxicol Appl Pharmacol; 2002 Aug; 182(3):208-18. PubMed ID: 12183100
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Arsenate reduction in human erythrocytes and rats--testing the role of purine nucleoside phosphorylase.
    Nemeti B; Csanaky I; Gregus Z
    Toxicol Sci; 2003 Jul; 74(1):22-31. PubMed ID: 12730608
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Bacterial ability in AsIII oxidation and AsV reduction: Relation to arsenic tolerance, P uptake, and siderophore production.
    Ghosh P; Rathinasabapathi B; Teplitski M; Ma LQ
    Chemosphere; 2015 Nov; 138():995-1000. PubMed ID: 25576133
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Polynucleotide phosphorylase and mitochondrial ATP synthase mediate reduction of arsenate to the more toxic arsenite by forming arsenylated analogues of ADP and ATP.
    Németi B; Regonesi ME; Tortora P; Gregus Z
    Toxicol Sci; 2010 Oct; 117(2):270-81. PubMed ID: 20457661
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In vivo reduction of arsenate in mice and rabbits.
    Vahter M; Envall J
    Environ Res; 1983 Oct; 32(1):14-24. PubMed ID: 6617606
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Glutathione-dependent reduction of arsenate in human erythrocytes--a process independent of purine nucleoside phosphorylase.
    Németi B; Gregus Z
    Toxicol Sci; 2004 Dec; 82(2):419-28. PubMed ID: 15470234
    [TBL] [Abstract][Full Text] [Related]  

  • 14. High As exposure induced substantial arsenite efflux in As-hyperaccumulator Pteris vittata.
    Chen Y; Fu JW; Han YH; Rathinasabapathi B; Ma LQ
    Chemosphere; 2016 Feb; 144():2189-94. PubMed ID: 26595313
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Glutathione-supported arsenate reduction coupled to arsenolysis catalyzed by ornithine carbamoyl transferase.
    Németi B; Gregus Z
    Toxicol Appl Pharmacol; 2009 Sep; 239(2):154-61. PubMed ID: 19248796
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Reduction of arsenate to arsenite by human erythrocyte lysate and rat liver cytosol - characterization of a glutathione- and NAD-dependent arsenate reduction linked to glycolysis.
    Németi B; Gregus Z
    Toxicol Sci; 2005 Jun; 85(2):847-58. PubMed ID: 15788720
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mechanism of thiol-supported arsenate reduction mediated by phosphorolytic-arsenolytic enzymes: II. Enzymatic formation of arsenylated products susceptible for reduction to arsenite by thiols.
    Gregus Z; Roos G; Geerlings P; Németi B
    Toxicol Sci; 2009 Aug; 110(2):282-92. PubMed ID: 19478237
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Thyrotoxicity of arsenate and arsenite on juvenile mice at organism, subcellular, and gene levels under low exposure.
    Sun HJ; Li SW; Li C; Wang WQ; Li HB; Ma LQ
    Chemosphere; 2017 Nov; 186():580-587. PubMed ID: 28813693
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Reduction of arsenate to arsenite in hepatic cytosol.
    Németi B; Gregus Z
    Toxicol Sci; 2002 Nov; 70(1):4-12. PubMed ID: 12388829
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Arsenic uptake, arsenite efflux and plant growth in hyperaccumulator Pteris vittata: Role of arsenic-resistant bacteria.
    Han YH; Fu JW; Chen Y; Rathinasabapathi B; Ma LQ
    Chemosphere; 2016 Feb; 144():1937-42. PubMed ID: 26547029
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.